Gene Query: CYCS

Dataset Description Geneva Score
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 65.73
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 65.73
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 61.01
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 55.16
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 55.16
RIG-I and MDA5 fRIP during KSHV lytic reactivation 46.36
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 45.24
Targeting EZH2 in MYCN-amplified Neuroblastoma 45.24
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 44.36
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 44.36
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 38.89
FOXD3 is a novel tumor suppressor in lung cancer 35.89
Transcriptomic profiling of human peripheral blood-derived mast cells 35.09
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 35.09
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 34.7
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 33.3
MARS Seq data from human cortical organoids 33.03
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 32.66
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 32.36
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 31.76
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 31.56
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 31.48
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 30.57
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 30.57
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 30.17
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 29.75
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 29.55
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 27.76
Differetially expressed genes after hTR overexpression in U2OS cells 27.63
Differential expression of genes in AD169-infected MRC5. 27.44
Expression level comparison under dividing and quiescent states in human primary fibroblasts 26.67
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 26.16
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 25.66
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 25.66
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 25.62
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 25.62
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 25.49
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 25.42
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 25.23
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 25.14
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 25.03
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 24.57
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 24.25
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 24.04
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 23.88
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 23.88
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 23.41
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 23.07
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 22.88
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 22.58
Determination of tRNA aminoacylation levels by high throughput sequencing 22.0
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 21.81
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 21.81
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 21.72
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 21.13
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 21.05
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 20.93
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 20.92
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 20.86
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 20.83
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 20.83
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 20.6
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 20.48
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 20.47
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 20.05
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 19.87
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 19.87
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 19.84
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 19.81
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 19.81
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 19.69
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 19.69
Role of microRNAs in the interaction between Salmonella and the host cell 19.62
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 19.45
RNA-sequencing of human liver tissue 18.58
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 18.52
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 18.24
Transcriptome of human white and brown adipose tissue biopsies 18.18
Regulating Interleukin-2 activity with engineered receptor signaling clamps 18.02
Endothelial gene expression analysis 17.99
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 17.99
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 17.91
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 17.89
Co-transcriptional loading of RNA export factors shapes the human transcriptome 17.86
RNAseq of HEK293 cells after Chtop knockdown 17.86
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 17.84
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 17.78
Role of cervicovaginal microbiota in genital inflammation 17.57
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 17.42
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 17.42
Identification of transcription start sites for human A549 cell line using ReCappable-seq 17.39
RNA-Seq with and without RNase treatment in PCa cell lines 17.33
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 17.25
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 17.14
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 17.1
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 17.08
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 16.97
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 16.96
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 16.92
Ribosomal footprinting of CN34-Parental and CN34-LM1a 16.83
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 16.71
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 16.65
MeRIP-seq for heat shock in B-cell lymphoma cells 16.47
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 16.32
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 16.25
RNA-seq of resting and activated CD4+ T cells +-JQ1 16.12
KLF6-dependent transcription in renal cancer cells 16.06
Global analysis of enhancer targets: Mosaic-seq 16.04
Human cell line and subcutaneous tumor 16.0
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 15.98
RNA-seq melanoma 15.85
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 15.84
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 15.79
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 15.73
Transcriptome of activated human and mouse MAIT cells 15.63
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 15.6
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 15.54
BACH2 in human plasma cell fate decision 15.47
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 15.47
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 15.46
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 15.43
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 15.43
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 15.38
Argonaute proteins couple chromatin silencing to alternative splicing 15.37
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 15.37
Differentially expressed vascular development genes for iPSC-ECs from CDI 15.37
Fibroblasts in cholesteatoma activate osteoclasts. 15.18
Primary human trophoblast from term placenta 15.16
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 15.08
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 15.08
Profiling of escape kinetics of viruses subjected to RNAi 14.96
3’ Uridylation Expands miRNA Target Repertoire 14.61
RNA-seq analysis of RALD iPSCs after in vitro differentiation 14.6
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 14.5
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 14.29
Ribosomal footprinting of MDA-Parental and MDA-LM2 14.19
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 14.1
NRDE2 negatively regulates nuclear exosome functions 14.07
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 14.03
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 14.03
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 13.99
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 13.99
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 13.99
Gene expression analysis of immortalized human liver progenitor-like cells in culture 13.89
Transcriptomic analysis of the HOTAIR-regulated genes 13.71
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 13.69
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 13.61
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 13.61
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 13.57
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 13.57
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 13.57
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 13.39
Transcriptome analysis upon C6orf203 silencing 13.39
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 13.36
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 13.35
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 13.31
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 13.2
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 13.15
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 13.1
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 13.08
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 13.02
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 12.94
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 12.8
MicroRNA targetome analysis during HCMV infection 12.78
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 12.66
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 12.66
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 12.63
Maturation of human iNSCs 12.46
UV_24h_GRO-Seq 12.44
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 12.44
Primary Human B-cell Temporal Response to CD40L Stimulation 12.39
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 12.38
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 12.35
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 12.34
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 12.34
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 12.15
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 12.11
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 12.11
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 12.09
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 12.08
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 11.94
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 11.94
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 11.94
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 11.89
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 11.89
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 11.85
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 11.78
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 11.74
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 11.72
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 11.71
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 11.7
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 11.65
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 11.63
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 11.56
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 11.47
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 11.45
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 11.43
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 11.37
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 11.3
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 11.12
METTL3 promotes translation in human cancer cells 11.11
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 11.07
CROP-Seq in Primary Human T Cells 10.97
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 10.94
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 10.94
Trans-differentiation of human adult peripheral blood T cells into neurons 10.93
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 10.92
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 10.89
Short and Long RNA sequencing of human mature erythrocytes 10.86
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 10.84
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 10.81
Global expression profiles in cardiac progenitor cells generated by ISX-9 10.81
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 10.76
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 10.76
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 10.75
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 10.64
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 10.63
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 10.57
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 10.57
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 10.55
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 10.55
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 10.55
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 10.55
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 10.52
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 10.47
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 10.43
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 10.42
Molecular Mechanisms of Endothelial Hyperpermeability 10.41
Genome wide miR-191 target profile determined by RIP and gene expression profiling 10.4
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 10.4
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 10.39
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 10.31
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 10.31
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 10.25
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 10.19
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 10.17
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 10.15
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 10.13
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 10.13
miR941 overexpression experiment 10.12
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 10.08
An acquired vulnerability of drug resistant melanoma with therapeutic potential 10.08
The pioneer factor CEBPA modulates vitamin D signaling 10.06
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 10.06
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 10.06
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 10.05
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 9.99
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 9.98
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 9.94
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 9.85
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 9.85
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 9.85
Genome-wide discovery of human splicing branchpoints [RNAse] 9.76
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 9.76
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 9.76
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 9.75
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 9.73
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 9.67
Genome-wide functional assessment of enhancer activities in the human genome 9.67
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 9.62
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 9.61
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 9.59
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 9.54
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 9.53
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 9.46
Noncoding regions are the main source of targetable tumor-specific antigens 9.39
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 9.33
RNA-seq of RKO cells with cTAZ KO or putback 9.32
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 9.32
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 9.3
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 9.22
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 9.17
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 9.15
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 9.14
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 9.12
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 9.06
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 9.03
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 9.03
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 8.98
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 8.98
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 8.98
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 8.92
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 8.87
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 8.87
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 8.78
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 8.77
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 8.77
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 8.68
Overexpression and knockdown experiment for circCSNK1G3 8.58
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 8.57
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 8.49
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 8.38
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 8.34
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 8.34
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 8.26
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 8.2
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 8.18
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 8.15
CD73 knockdown effect in pancreatic cancer cell lines 8.03
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 8.03
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 7.98
FOXP2's impact on the primate transcriptome 7.93
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 7.88
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 7.85
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 7.75
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 7.7
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 7.62
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 7.51
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 7.5
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 7.47
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 7.44
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 7.41
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 7.4
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 7.32
Interaction between mitoNEET and NAF-1 in cancer cells 7.28
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 7.28
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 7.24
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 7.2
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 7.19
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 7.13
The transcriptome effect of overexpressing EZH2 in MCF7 7.12
Global Mapping of Human RNA-RNA Interactions 7.04
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 7.03
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 6.97
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 6.97
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 6.97
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 6.85
RNA Seq of HMVEC under hypoxia 6.85
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 6.85
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 6.75
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 6.72
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 6.66
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 6.66
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 6.61
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 6.61
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 6.44
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 6.37
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 6.34
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 6.31
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 6.23
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 6.23
Effect of PRDM11 depletion in U2932 cells 6.14
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 6.14
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 6.12
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 6.12
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 6.09
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 6.05
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 6.03
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 6.03
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 5.99
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 5.97
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 5.96
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 5.95
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 5.93
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 5.82
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 5.69
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 5.67
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 5.63
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 5.62
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 5.62
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 5.61
oxLDL exposed trained monocytes 5.58
Transcriptomes of oxLDL exposed trained monocytes 5.58
Exogenous rescue of KLHL9 in SF210 cell line 5.54
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 5.52
Gene expression profiling of KSHV-infected periodontal ligament cells 5.52
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 5.52
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 5.47
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 5.19
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 5.1
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 4.86
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 4.86
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 4.85
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 4.85
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 4.83
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 4.76
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 4.76
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 4.75
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 4.75
RNAseq in Alzheimer's Disease patients 4.74
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 4.7
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 4.62
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 4.62
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 4.6
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 4.54
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 4.51
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 4.43
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 4.33
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 4.3
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 4.21
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 4.17
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 4.16
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 4.14
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 4.14
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 4.14
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 4.09
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 4.08
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 4.03
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 3.91
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 3.8
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.76
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.76
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 3.76
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 3.72
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 3.69
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 3.69
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 3.68
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 3.59
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 3.59
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 3.49
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 3.47
Triple vectors expand AAV transfer capacity in the retina 3.41
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 3.4
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 3.35
The transcriptome of Kawasaki Disease arteritis 3.35
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 3.27
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 3.11
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 3.11
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 3.11
Comparative Analysis of Cas9 Activators Across Multiple Species 3.07
nELAVL HITS-CLIP in Alzheimer's Disease patients 3.05
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 2.96
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.95
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 2.94
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 2.94
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 2.93
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 2.89
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 2.79
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 2.76
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 2.71
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 2.68
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 2.68
6mer seed toxicity in viral microRNAs 2.61
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 2.56
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 2.56
MicroRNA-125a-5p overexpression in human macrophages 2.56
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 2.54
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 2.5
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 2.46
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 2.4
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 2.31
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 2.26
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.23
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.19
Dilated cardiomyopathy vs Myocarditis 2.18
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 2.15
Transcriptome-wide response to synthetic chromatin protein PcTF 2.14
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 2.1
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 2.08
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 2.01
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 1.91
Determining mRNA half-lives on a transcriptome-wide scale 1.9
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 1.83
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 1.78
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.74
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 1.64
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 1.49
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 1.42
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 1.42
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.38
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.37
Retinoic acid suppresses MYB in adenoid cystic carcinoma 1.36
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 1.36
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 1.33
LINE-2 transposable elements are a source of functional human microRNAs and target sites 1.26
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 1.14
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.14
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 0.99
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.92
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 0.91
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.91
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.84
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.78
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.76
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.58
mRNA expression in human DAOY cells 0.56
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 0.48
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.48
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.46
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.46
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.39
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.37
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 0.35
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.33
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.33
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.33
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.32
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.27
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.22
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 0.21
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 0.21
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 0.2
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 0.18
mRNA recovered upon RNF219 IP. [RNA-IP] 0.12
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 0.12
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.1
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.07
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.05
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.02
Trascriptome of thyroid cancer-induced macrophages 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation